Antimicrobial Agents Practice Questions

Q: Which of the following represents an orally available fixed Beta-Lactamase Inhibitor and Antibiotic Combination?

Amoxicillin-Clavulanic acid. ### Explanation The correct answer is **Amoxicillin-Clavulanic acid**. **1. Why Amoxicillin-Clavulanic acid is correct:** The primary factor determining the route of administration for beta-lactam combinations is the **acid stability** and **bioavailability** of both components. Amoxicillin is acid-stable and highly absorbed from the gastrointestinal tract. Clavulanic acid also possesses excellent oral bioavailability. Together, they form a fixed-dose combination (e.g., Augmentin) that is effective orally for community-acquired infections like sinusitis, otitis media, and animal bites. **2. Why the other options are incorrect:** * **Ampicillin-Sulbactam:** While ampicillin can be given orally, its absorption is inconsistent and decreased by food. Sulbactam has very poor oral bioavailability. Therefore, this combination is administered **parenterally** (IV/IM). (Note: *Sultamicillin* is an oral prodrug of this combination, but the standard combination listed is parenteral). * **Piperacillin-Tazobactam:** Piperacillin is a broad-spectrum antipseudonal penicillin that is degraded by gastric acid. It must be administered **intravenously**. It is a mainstay for hospital-acquired infections. * **Ticarcillin-Clavulanic Acid:** Ticarcillin is not acid-stable and is only available for **parenteral** use. **3. High-Yield NEET-PG Pearls:** * **Suicide Inhibitors:** Clavulanic acid, Sulbactam, and Tazobactam are "suicide inhibitors" because they permanently bind to and inactivate beta-lactamases. * **Newer Agents:** Avibactam and Relebactam are non-beta-lactam beta-lactamase inhibitors used with carbapenems or cephalosporins for MDR organisms. * **Sultamicillin:** This is a double ester of Ampicillin and Sulbactam, designed specifically to provide an **oral** formulation of that combination. * **Side Effect:** Amoxicillin-Clavulanate is a common cause of drug-induced cholestatic jaundice.

Q: Which monoclonal antibody neutralizes anthrax toxin?

Raxibacumab. **Explanation:** **Raxibacumab** is a recombinant human IgG1 monoclonal antibody specifically designed to treat inhalational anthrax caused by *Bacillus anthracis*. Its mechanism of action involves binding to the **Protective Antigen (PA)** component of the anthrax toxin. By neutralizing PA, it prevents the toxin from binding to host cell receptors, thereby inhibiting the entry of Lethal Factor (LF) and Edema Factor (EF) into the cells. This prevents the systemic toxemia that often leads to death even after the bacteria have been cleared by antibiotics. (Note: **Obiltoxaximab** is another mAb with a similar mechanism). **Analysis of Incorrect Options:** * **Cetuximab:** A chimeric monoclonal antibody that targets the **Epidermal Growth Factor Receptor (EGFR)**. It is primarily used in the treatment of metastatic colorectal cancer and head and neck squamous cell carcinoma. * **Panitumumab:** A fully human monoclonal antibody that also targets **EGFR**. It is used for the treatment of EGFR-expressing metastatic colorectal cancer. * **Alemtuzumab:** A monoclonal antibody directed against **CD52**, a protein found on the surface of mature lymphocytes. It is used in the treatment of B-cell chronic lymphocytic leukemia (CLL) and Multiple Sclerosis (MS). **High-Yield Clinical Pearls for NEET-PG:** * **Anthrax Toxin Components:** It is a tripartite toxin consisting of Protective Antigen (PA), Lethal Factor (LF), and Edema Factor (EF). * **Drug of Choice:** While Raxibacumab manages the toxin, the antibiotic drug of choice for post-exposure prophylaxis and treatment of Anthrax is **Ciprofloxacin** (or Doxycycline). * **Bezlotoxumab:** Do not confuse Raxibacumab with Bezlotoxumab, which is a monoclonal antibody used to prevent the recurrence of *Clostridioides difficile* infection by neutralizing Toxin B.

Q: Tecovirimat is a recently approved anti-viral drug. Against which virus is it used?

Smallpox. **Explanation:** **Tecovirimat** is a novel, first-in-class antiviral medication specifically developed and approved for the treatment of **Smallpox** (caused by the *Variola virus*). It was approved by the FDA under the "Animal Rule" to bolster biodefense preparedness. **Mechanism of Action:** Tecovirimat works by inhibiting the **VP37 envelope wrapping protein**, which is highly conserved across orthopoxviruses. By blocking this protein, the drug prevents the formation of egress-competent enveloped virions, thereby stopping the virus from spreading from cell to cell within the host. **Analysis of Incorrect Options:** * **B. Chickenpox:** Caused by the *Varicella-Zoster Virus* (a herpesvirus). The standard treatment involves DNA polymerase inhibitors like **Acyclovir** or Valacyclovir. Tecovirimat is ineffective against herpesviruses. * **C. Dengue:** A flavivirus for which there is currently no specific antiviral therapy. Management is primarily supportive (fluid resuscitation). * **D. Influenza:** Treated with neuraminidase inhibitors (e.g., **Oseltamivir**), endonuclease inhibitors (e.g., **Baloxavir marboxil**), or M2 ion channel blockers (e.g., Amantadine). **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** While approved for Smallpox, it also shows efficacy against other orthopoxviruses, including **Mpox (Monkeypox)** and Cowpox. * **Route:** Available in both oral and intravenous formulations. * **Resistance:** Resistance can develop via a single amino acid substitution in the VP37 protein; hence, it is often reserved for severe cases or biosecurity threats. * **Key Target:** Remember **VP37**—this is a frequent target for "mechanism of action" questions in recent exams.

Q: All of the following drugs inhibit cell wall synthesis except?

Tetracycline. **Explanation:** The cell wall is a vital structure in bacteria, and drugs targeting its synthesis are generally bactericidal. To answer this question, one must distinguish between cell wall synthesis inhibitors and protein synthesis inhibitors. **Why Tetracycline is the correct answer:** **Tetracycline** is a bacteriostatic antibiotic that inhibits **protein synthesis**, not cell wall synthesis. It acts by reversibly binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. **Why the other options are incorrect:** * **Penicillin:** A Beta-lactam antibiotic that inhibits the final step of cell wall synthesis (transpeptidation) by binding to Penicillin-Binding Proteins (PBPs). * **Fosfomycin:** Inhibits the very first step of peptidoglycan synthesis by inhibiting the enzyme **MurA** (enolpyruvate transferase), preventing the formation of UDP-NAM. * **Vancomycin:** A glycopeptide that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing transglycosylation and transpeptidation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cell Wall Inhibitors:** "**P**enis **C**an't **B**eat **V**irgin **F**annies" (**P**enicillins, **C**ephalosporins, **B**acitracin, **V**ancomycin, **F**osfomycin/Cycloserine). * **Tetracycline Side Effects:** Fanconi syndrome (expired tetracyclines), tooth discoloration, and phototoxicity. * **Fosfomycin** is a first-line drug for uncomplicated UTIs (safe in pregnancy). * **Vancomycin** is the drug of choice for MRSA but can cause "Red Man Syndrome" due to histamine release if infused too rapidly.

Q: What is the drug of choice for treating P. vivax malaria in a pregnant woman?

Chloroquine. ### Explanation **Correct Option: B. Chloroquine** **Mechanism and Rationale:** Chloroquine remains the **drug of choice (DOC)** for sensitive *Plasmodium vivax* and *P. falciparum* malaria during all trimesters of pregnancy. It is highly effective against the erythrocytic stages of the parasite and has a well-established safety profile in pregnancy, showing no teratogenic effects. In *P. vivax* cases, Chloroquine clears the current infection; however, **Primaquine**, which is used for radical cure (to kill hypnozoites in the liver), is **strictly contraindicated** in pregnancy due to the risk of severe hemolysis in the fetus (who may be G6PD deficient). Therefore, pregnant women are maintained on Chloroquine prophylaxis until delivery. **Analysis of Incorrect Options:** * **A. Quinine:** While safe in pregnancy, it is generally reserved for Chloroquine-resistant malaria or severe/complicated malaria. It is not the first-line choice for uncomplicated *P. vivax*. * **C. Artemether:** Part of Artemisinin-based Combination Therapy (ACT). While ACTs are now used in the 2nd and 3rd trimesters for *P. falciparum*, Chloroquine is still preferred for *P. vivax* unless resistance is documented. * **D. Paracetamol:** This is an antipyretic used for symptomatic relief of fever; it has no antimalarial activity and cannot treat the underlying infection. **High-Yield Clinical Pearls for NEET-PG:** * **Radical Cure Delay:** In *P. vivax* pregnancy cases, give Chloroquine (treatment) followed by weekly Chloroquine (prophylaxis) until delivery. Administer Primaquine only **after** delivery and after checking the G6PD status of the mother and infant. * **Severe Malaria in Pregnancy:** Intravenous **Artesunate** is the DOC for severe malaria in all trimesters (benefits outweigh risks). * **Contraindicated in Pregnancy:** Primaquine, Pyrimethamine (relative), and Tetracyclines (Doxycycline).

Q: Which of the following is a Dihydropteroate synthase (DHPS) inhibitor?

Dapsone. ### Explanation **Mechanism of Action: Folic Acid Synthesis Inhibition** Bacteria and certain protozoa must synthesize their own folic acid to produce DNA. This pathway occurs in two major steps: 1. **Step 1:** PABA (Para-aminobenzoic acid) is converted to Dihydrofolic acid by the enzyme **Dihydropteroate synthase (DHPS)**. 2. **Step 2:** Dihydrofolic acid is converted to Tetrahydrofolic acid by the enzyme **Dihydrofolate reductase (DHFR)**. **Dapsone** (a sulfone) is a structural analog of PABA. It competitively inhibits **Dihydropteroate synthase (DHPS)**, thereby halting the synthesis of folic acid. This is the same mechanism used by Sulfonamides (e.g., Sulfadiazine). --- ### Analysis of Options * **D. Dapsone (Correct):** As a sulfone, it specifically targets DHPS. It is a cornerstone drug in the MDT (Multi-Drug Therapy) for Leprosy. * **A. Pyrimethamine (Incorrect):** This is a **DHFR inhibitor** primarily used in the treatment of Toxoplasmosis and Malaria. * **B. Trimethoprim (Incorrect):** This is a potent bacterial **DHFR inhibitor**. It is commonly combined with Sulfamethoxazole (a DHPS inhibitor) to create a sequential blockade (Cotrimoxazole). * **C. Methotrexate (Incorrect):** This is a human **DHFR inhibitor** used as a cytotoxic chemotherapy agent and an immunosuppressant (e.g., in Rheumatoid Arthritis). --- ### NEET-PG High-Yield Pearls * **Sequential Blockade:** Combining a DHPS inhibitor (Sulfonamide) with a DHFR inhibitor (Trimethoprim) results in synergistic bactericidal activity. * **Dapsone Side Effects:** Most common is **Hemolysis** (especially in G6PD deficient patients) and **Methemoglobinemia**. * **Lepra Reaction:** Dapsone is continued during Type 1 reactions but may be associated with the "Dapsone Syndrome" (sulfone syndrome), characterized by fever, dermatitis, and hepatitis.

Q: After treatment of pneumonia, a child developed pseudomembranous colitis. Which of the following drugs frequently causes pseudomembranous colitis?

Clindamycin. ### Explanation **Correct Option: A (Clindamycin)** Pseudomembranous colitis (PMC) is caused by the overgrowth of *Clostridioides difficile* (formerly *Clostridium*) following the suppression of normal intestinal flora by broad-spectrum antibiotics. While almost any antibiotic can trigger PMC, **Clindamycin** is classically associated with the highest risk relative to its usage. It effectively kills anaerobic bacteria in the gut, allowing *C. difficile* to proliferate and release toxins (Toxin A and B), leading to mucosal inflammation and "pseudomembrane" formation. **Analysis of Incorrect Options:** * **B. Gentamicin:** This is an aminoglycoside. Aminoglycosides are primarily active against aerobic gram-negative bacilli and have minimal impact on the anaerobic intestinal flora; therefore, they rarely cause PMC. * **C. Erythromycin:** While macrolides can cause gastrointestinal upset (via motilin receptor stimulation), they are less frequently implicated in PMC compared to Clindamycin, Fluoroquinolones, or Cephalosporins. * **D. Vancomycin:** Oral Vancomycin is actually a **treatment** for PMC. It is not a cause because it is highly effective against *C. difficile*. (Note: Intravenous vancomycin is ineffective for PMC as it does not reach the gut lumen). **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause overall:** Currently, **Fluoroquinolones**, Cephalosporins (2nd/3rd gen), and Ampicillin/Amoxicillin are the most frequent causes due to their high volume of prescription. * **Drug of Choice (DOC):** **Fidaxomicin** or **Oral Vancomycin** are preferred first-line agents. Metronidazole is now reserved for non-severe cases if other options are unavailable. * **Diagnosis:** Confirmed by detecting *C. difficile* toxins in stool or via colonoscopy showing yellowish-white plaques (pseudomembranes).

Q: Caspofungin is an antifungal which acts on which cellular component?

Cell wall. **Explanation:** **Mechanism of Action (Why A is correct):** Caspofungin belongs to the **Echinocandin** class of antifungals. It acts by non-competitively inhibiting the enzyme **1,3-beta-D-glucan synthase**. This enzyme is responsible for synthesizing beta-glucan, a vital structural polysaccharide in the fungal **cell wall**. Inhibition leads to osmotic instability and cell lysis. Since mammalian cells lack a cell wall and beta-glucans, this mechanism offers high selectivity. **Analysis of Incorrect Options:** * **B. Cell membrane:** This is the site of action for **Polyenes** (e.g., Amphotericin B, Nystatin), which bind to ergosterol, and **Azoles** (e.g., Fluconazole), which inhibit ergosterol synthesis. * **C. Mitochondria:** While some experimental drugs target fungal mitochondria, no major clinical antifungal class used in NEET-PG contexts primarily targets this organelle. * **D. Nucleic acid:** **Flucytosine (5-FC)** acts here. It is converted to 5-fluorouracil, which inhibits DNA and RNA synthesis. **Griseofulvin** also interferes with mitosis by binding to microtubules. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Caspofungin is the first-line treatment for invasive **Candidiasis** and is used as salvage therapy for invasive **Aspergillosis**. * **Route:** It is administered only via **IV infusion** (poor oral bioavailability). * **Side Effects:** Generally well-tolerated; may cause "infusion-related reactions" due to histamine release. * **Mnemonic:** Remember the **"3 C's"** for Echinocandins: **C**aspofungin, **C**andins, **C**ell wall.

Q: Maraviroc is used in the treatment of which condition?

Human Immunodeficiency Virus (HIV). **Explanation:** **Maraviroc** is a specialized antiretroviral drug used in the management of **Human Immunodeficiency Virus (HIV-1)**. Its mechanism of action is unique as it acts as a **CCR5 receptor antagonist** (Entry Inhibitor). 1. **Why Option C is Correct:** To enter a host T-cell, the HIV surface glycoprotein **gp120** must bind to the CD4 receptor and then to a co-receptor, either **CCR5** or **CXCR4**. Maraviroc selectively binds to the host cell's CCR5 receptor, preventing the viral gp120 from attaching. This blocks the fusion and entry of "R5-tropic" HIV strains into the cell. 2. **Why Other Options are Incorrect:** * **Options A & B (CMV and HSV):** These are DNA viruses belonging to the Herpesviridae family. They are treated with DNA polymerase inhibitors like **Ganciclovir** (for CMV) or **Acyclovir** (for HSV), which do not utilize the CCR5 pathway. * **Option D (Measles):** Measles is a Paramyxovirus. Treatment is primarily supportive, though Vitamin A is administered to reduce morbidity. Maraviroc has no activity against RNA viruses outside of specific HIV-1 strains. **High-Yield Clinical Pearls for NEET-PG:** * **Tropism Requirement:** Before starting Maraviroc, a **Trofile assay** must be performed. It is only effective against **CCR5-tropic (R5)** virus and ineffective against CXCR4 (X4) or dual-tropic viruses. * **Metabolism:** It is a substrate of **CYP3A4**; therefore, dosage adjustments are required when co-administered with protease inhibitors (inhibitors) or Efavirenz (inducer). * **Site of Action:** Unlike most antivirals that target viral enzymes, Maraviroc targets a **host cell protein**.

Q: Which of the following drugs is most effective for the radical cure of Plasmodium vivax malaria?

Chloroquine + Primaquine. **Explanation:** The treatment of *Plasmodium vivax* malaria requires a dual approach to address different stages of the parasite’s life cycle. This is known as **Radical Cure**, which aims to achieve both clinical cure (clearing blood stages) and prevention of relapse (clearing liver stages). 1. **Why Option C is Correct:** * **Chloroquine** is a potent schizonticide that eliminates the erythrocytic (blood) stages of the parasite, thereby relieving clinical symptoms. * **Primaquine** is a tissue schizonticide that targets the **hypnozoites** (dormant forms) in the liver. Without Primaquine, these hypnozoites can reactivate, causing a relapse. * The combination is essential because neither drug alone can achieve a complete cure and prevent recurrence. 2. **Why Other Options are Incorrect:** * **Option A (Chloroquine):** While it treats the acute attack, it has no effect on liver hypnozoites. Using it alone leads to high relapse rates. * **Option B (Primaquine):** While it kills liver stages, it is a weak blood schizonticide and is not used alone to treat an acute clinical attack of malaria. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen (NVBDCP India):** Chloroquine (25 mg/kg over 3 days) + Primaquine (0.25 mg/kg daily for **14 days**). * **G6PD Deficiency:** Before administering Primaquine, patients must be screened for G6PD deficiency, as the drug can trigger **acute hemolysis**. * **Pregnancy:** Primaquine is **contraindicated** in pregnancy and infants under 6 months due to the risk of neonatal hemolysis. * **Relapse vs. Recrudescence:** Relapse is unique to *P. vivax* and *P. ovale* due to hypnozoites; recrudescence occurs in *P. falciparum* due to incomplete clearance of blood stages.

Question 1

Which of the following represents an orally available fixed Beta-Lactamase Inhibitor and Antibiotic Combination?

Accepted Answer

Amoxicillin-Clavulanic acid

Answer

Ampicillin-Sulbactam

Answer

Piperacillin-Tazobactam

Answer

Ticarcillin-Clavulanic Acid

Question 2

Which monoclonal antibody neutralizes anthrax toxin?

Accepted Answer

Raxibacumab

Answer

Cetuximab

Answer

Panitumumab

Answer

Alemtuzumab

Question 3

Tecovirimat is a recently approved anti-viral drug. Against which virus is it used?

Accepted Answer

Smallpox

Answer

Chickenpox

Answer

Dengue

Answer

Influenza

Question 4

All of the following drugs inhibit cell wall synthesis except?

Accepted Answer

Tetracycline

Answer

Penicillin

Answer

Fosfomycin

Answer

Vancomycin

Question 5

What is the drug of choice for treating P. vivax malaria in a pregnant woman?

Accepted Answer

Chloroquine

Answer

Quinine

Answer

Artemether

Answer

Paracetamol

Question 6

Which of the following is a Dihydropteroate synthase (DHPS) inhibitor?

Accepted Answer

Dapsone

Answer

Pyrimethamine

Answer

Trimethoprim

Answer

Methotrexate

Question 7

After treatment of pneumonia, a child developed pseudomembranous colitis. Which of the following drugs frequently causes pseudomembranous colitis?

Accepted Answer

Clindamycin

Answer

Gentamicin

Answer

Erythromycin

Answer

Vancomycin

Question 8

Caspofungin is an antifungal which acts on which cellular component?

Accepted Answer

Cell wall

Answer

Cell membrane

Answer

Mitochondria

Answer

Nucleic acid

Question 9

Maraviroc is used in the treatment of which condition?

Accepted Answer

Human Immunodeficiency Virus (HIV)

Answer

Cytomegalovirus (CMV)

Answer

Herpes Simplex Virus (HSV)

Answer

Measles

Question 10

Which of the following drugs is most effective for the radical cure of Plasmodium vivax malaria?

Accepted Answer

Chloroquine + Primaquine

Answer

Chloroquine

Answer

Primaquine

Answer

None of the above

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?